Why can patients with erectile dysfunction be considered lucky? The association with testosterone deficiency and metabolic syndrome

被引:89
作者
Corona, G. [1 ,2 ]
Forti, G. [1 ]
Maggi, M. [1 ]
机构
[1] Univ Florence, Dept Clin Physiopathol, Androl Unit, I-50139 Florence, Italy
[2] Maggiore Bellaria Hosp, Endocrine Unit, Bologna, Italy
关键词
Hypogonadism; metabolic syndrome; testosterone; FXR; androgen receptor; erectile dysfunction;
D O I
10.1080/13685530802468497
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Metabolic syndrome (MetS) is a diagnostic category, based on a cluster of risk factors (hyperglycemia/diabetes, abdominal obesity, hypertriglyceridaemia, low HDL cholesterol and hypertension), which identifies subjects at high risk for forthcoming type 2 diabetes mellitus and cardiovascular (CV) diseases. Recently, a close association between MetS, erectile dysfunction (ED) and male hypogonadism has been reported. In patients with MetS, hypogonadism can exacerbate sexual dysfunction and arteriogenic ED because of its typical symptoms, such as decreased sexual desire and mood disturbances. On the other hand, hypogonadism per se has been associated with an increased risk of CV and overall mortality. Obesity and in particular central obesity is nowadays considered the most important determinant of MetS-induced hypogonadism whereas hypertension and diabetes play a major role in ED associated with MetS. This review analyses the current literature regarding the relationship between ED, MetS and hypogonadism emphasising the epidemiological and psychopathological aspects and stressing the concept that ED subjects are 'lucky', because ED offers a unique chance to undergo medical examination and therefore to improve not only their sexual but, most importantly, their overall health.
引用
收藏
页码:193 / 199
页数:7
相关论文
共 72 条
[51]   Investigation, treatment and monitoring of late-onset hypogonadism in males ISA, ISSAM, and EAU recommendations [J].
Nieschlag, E ;
Swerdloff, R ;
Behre, HM ;
Gooren, LJ ;
Kaufman, JM ;
Legros, JJ ;
Lunenfeld, B ;
Morley, JE ;
Schulman, C ;
Wang, C ;
Weidner, W ;
Wu, FCW .
EUROPEAN UROLOGY, 2005, 48 (01) :1-4
[52]   Prevalence of overweight and obesity in the United States, 1999-2004 [J].
Ogden, CL ;
Carroll, MD ;
Curtin, LR ;
McDowell, MA ;
Tabak, CJ ;
Flegal, KM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (13) :1549-1555
[53]   Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo Study [J].
Oh, JY ;
Barrett-Connor, E ;
Wedick, NM ;
Wingard, DL .
DIABETES CARE, 2002, 25 (01) :55-60
[54]   SEX-HORMONES, RISK-FACTORS AND CARDIOVASCULAR-DISEASE [J].
PHILLIPS, GB .
AMERICAN JOURNAL OF MEDICINE, 1978, 65 (01) :7-11
[55]   Are overweight, obesity, and extreme obesity associated with psychopathology? Results from the national epidemiologic survey on alcohol and related conditions [J].
Pickering, Roger P. ;
Grant, Bridget F. ;
Chou, S. Patricia ;
Compton, Wilson M. .
JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (07) :998-1009
[56]   Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men [J].
Pitteloud, N ;
Mootha, VK ;
Dwyer, AA ;
Hardin, M ;
Lee, H ;
Eriksson, KF ;
Tripathy, DJ ;
Yialamas, M ;
Groop, L ;
Elahi, D ;
Hayes, FJ .
DIABETES CARE, 2005, 28 (07) :1636-1642
[57]   Increasing insulin resistance is associated with a decrease in Leydig cell testosterone secretion in men [J].
Pitteloud, N ;
Hardin, M ;
Dwyer, AA ;
Valassi, E ;
Yialamas, M ;
Elahi, D ;
Hayes, FJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (05) :2636-2641
[58]   The metabolic syndrome: Requiescat in pace [J].
Reaven, GM .
CLINICAL CHEMISTRY, 2005, 51 (06) :931-938
[59]   ROLE OF INSULIN RESISTANCE IN HUMAN-DISEASE [J].
REAVEN, GM .
DIABETES, 1988, 37 (12) :1595-1607
[60]   Psychiatric symptoms among prospective bariatric surgery patients: Rates of prevalence and their relation to social desirability, pursuit of surgery, and follow-up attendance [J].
Rosik, CH .
OBESITY SURGERY, 2005, 15 (05) :677-683